Clene Nanomedicine, Inc. is a clinical-stage biopharmaceutical company that develops nanoparticle-based medicines. Its filings show it hired a lobbying firm, likely to engage with federal policymakers on issues affecting its clinical development or regulatory matters. The disclosed activity is limited to one filing with no reported spending.
Show the dominant industry call, how mixed the client looks, and the allocation across the top labeled sectors.
Annual totals based on disclosed filing amounts.
Issue rankings are based on disclosed activity mentions, with filing amounts apportioned evenly across issues within the same filing.
This client has not yet disclosed issue activity in the available filings.
The lobbying registrants handling this client, ranked by disclosed filing amounts.
Lobbyists are ranked by appearances and an equal share of each filing's reported amount.
No lobbyists are disclosed for this client yet.
The latest disclosures for this client.
BEN BARNES GROUP LP
1TYThe entities named in disclosed activities are the clearest available signal for where the client is aiming attention.
This client's filings do not yet disclose named government entities.